Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | GRM5 | P41594 | 3/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP12 | P39900 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18674373 | 0.82 | FFAR1 (0.41) | FFAR1GRM5MMP12 | |
| SCHEMBL18674382 | 0.80 | GPR84 (0.36) | FFAR1GRM5 | |
| SCHEMBL18677577 | 0.77 | FFAR1 (0.43) | FFAR1GRM5MMP12 | |
| SCHEMBL17053267 | 0.76 | CNR1 (0.32) | KCNH2CNR1CNR2 | |
| SCHEMBL18674374 | 0.74 | FFAR1 (0.43) | FFAR1GRM5MMP12 | |
| SCHEMBL18674371 | 0.73 | GRM5 (0.41) | FFAR1GRM5MMP12 | |
| SCHEMBL13139113 | 0.70 | KCNH2 (0.46) | FFAR1KCNH2FFAR4MMP2MMP12 | |
| SCHEMBL13139110 | 0.70 | KCNH2 (0.46) | FFAR1KCNH2FFAR4MMP2MMP12 | |
| SCHEMBL11983252 | 0.69 | KCNH2 (0.45) | FFAR1KCNH2FFAR4MMP2MMP12 | |
| SCHEMBL18674372 | 0.69 | FFAR1 (0.40) | FFAR1GRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170092434-A1 | PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, AND DYE SOLUTION | FUJIFILM CORPORATION (JP) | 2017-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170092434-A1 | PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, AND DYE SOLUTION | CRY2, CRY1, MYL4 | FFAR1 4596/4885KCNH2 315/4885GRM5 2991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.